PubMed COVID-19 Clinical Care

No abstract

CONCLUSIONS: Tocilizumab improves clinical outcomes in hospitalized COVID-19 patients. These advantages were evident independent of the patient's comorbidities and were in addition to the advantages of systemic corticosteroids. In COVID-19 patients

The COVID-19 pandemic has exposed serious shortcomings in healthcare systems around the world. Shortages of staff, equipment and access to healthcare have created major obstacles for facilities when managing public health emergencies. The pandemic

Chronic inflammatory gastrointestinal diseases such as Crohn's disease (CD) and ulcerative colitis (UC) are known as inflammatory bowel disorders (IBD). Patients with inflammatory bowel illnesses are more susceptible to viral infections. In people

No abstract

Cytomegalovirus (CMV) infection is a major driver of accelerated immunosenescence related to CD28null T cells expansion. CMV infection and these proatherogenic T cells have been independently associated with cardiovascular disease and COVID-19

CONCLUSION: Increased plasma TNFα levels in the acute phase of COVID-19 predict the presence of long-term anosognosia scores and changes in limbic system functional connectivity.

Are people more or less likely to follow numerical advice that communicates uncertainty in the form of a confidence interval? Prior research offers competing predictions. Although some research suggests that people are more likely to follow the

Increased systemic levels of inflammatory cytokines have been associated with the development of pathophysiologic events during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To further explore differences in the pattern and

No abstract